90 related articles for article (PubMed ID: 17001885)
1. Pattern of fibronectin in hepatocellular carcinoma and its significance.
Gupta N; Kakkar N; Vasishta RK
Indian J Pathol Microbiol; 2006 Jul; 49(3):362-4. PubMed ID: 17001885
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinomas show abnormal expression of fibronectin protein.
Torbenson M; Wang J; Choti M; Ashfaq R; Maitra A; Wilentz RE; Boitnott J
Mod Pathol; 2002 Aug; 15(8):826-30. PubMed ID: 12181267
[TBL] [Abstract][Full Text] [Related]
3. Expression of fibronectin and laminin in the rat liver after partial hepatectomy, during carcinogenesis, and in transplantable hepatocellular carcinomas.
Sell S; Ruoslahti E
J Natl Cancer Inst; 1982 Nov; 69(5):1105-14. PubMed ID: 6290734
[TBL] [Abstract][Full Text] [Related]
4. Expression, localization and alternative splicing pattern of fibronectin messenger RNA in fibrotic human liver and hepatocellular carcinoma.
Matsui S; Takahashi T; Oyanagi Y; Takahashi S; Boku S; Takahashi K; Furukawa K; Arai F; Asakura H
J Hepatol; 1997 Nov; 27(5):843-53. PubMed ID: 9382972
[TBL] [Abstract][Full Text] [Related]
5. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
6. Appearance of fibronectin in putative preneoplastic lesions and in hepatocellular carcinoma during chemical hepatocarcinogenesis in rats and in human hepatomas.
Szendröi M; Lapis K; Zalatnai A; Robert L; Labat-Robert J
J Exp Pathol; 1984; 1(3):189-99. PubMed ID: 6100983
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
8. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 positivity in B and C hepatitis and hepatocellular carcinomas.
Yildiz L; Baris S; Aydin O; Kefeli M; Kandemir B
Hepatogastroenterology; 2008; 55(88):2207-10. PubMed ID: 19260506
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
11. [Expression of CXCR3 in hepatocellular carcinoma].
Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
[TBL] [Abstract][Full Text] [Related]
12. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of hepatocellular carcinoma evaluated by vascular endothelial growth factor expression.
Amaoka N; Osada S; Kanematsu M; Imai H; Tomita H; Tokuyama Y; Sakashita F; Nonaka K; Goshima S; Kondo H; Adachi Y
J Gastroenterol Hepatol; 2007 Dec; 22(12):2202-7. PubMed ID: 18031381
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
15. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
[TBL] [Abstract][Full Text] [Related]
16. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
[TBL] [Abstract][Full Text] [Related]
17. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma.
Li W; Gomez E; Zhang Z
J Exp Clin Cancer Res; 2007 Dec; 26(4):527-33. PubMed ID: 18365549
[TBL] [Abstract][Full Text] [Related]
19. Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma.
Guo L; Guo Y; Xiao S
Oncology; 2007; 72(5-6):410-6. PubMed ID: 18196928
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
